CGC

Canopy Growth Corp

Earnings

Here's What's Really Happening with Aphria's Stellar Earnings Report

Aphria reported its fiscal fourth-quarter earnings last week, and the company exceeded all expectations.

And it beat those estimates from underneath a cloud of short sellers' spurious innuendo, to boot.

After a quarter of overall decline in Canadian cannabis revenue, Aphria saw an increase of 85% – that's 85% sequentially and not year over year. The company also turned earnings before interest, tax, depreciation, and amortization (EBITDA) positive – albeit after adjustments and with help from a European pharmaceutical distribution business the company owns.

And to top it off, management's optimistic about the future.

So any investor could look at Aphria's reporting and conclude it had a great quarter. And they'd be dead on.

What might not be so obvious at first glance is that this company just showed investors how it was going to take the cannabis sector to the next level.

There’s much more here than meets the eye…

Stocks

These Are the 3 Best CBD Stocks to Buy Now

One of our best CBD stocks to buy now is poised to gain 172% over the next year.

And that’s because the CBD industry is about to explode.

In fact, it’s expecting 3,623% growth in just under three years.

The CBD market is already valued at $591 million since being legalized in the United States in December 2018.

But the Brightfield Group says this figure will soar to $22 billion by 2022.

This type of explosive growth is precisely why we’re so bullish on CBD stocks and the cannabis sector as a whole.

Read more here...

Stocks

You'll Want to Own Canopy Growth Forever, so Here Are Three Ways to Profit from It

Our Greg Miller’s bringing you the latest update on Canopy Growth following CEO Bruce Linton’s firing last week.

Not only is a shakeup in management common in startup companies, but it’s actually welcome so that the firm can reach its next level of success.

In fact, Greg’s going to show you three ways you can reap the most profits from this stock that you’ll want to keep in your portfolio for a long time…

Read more...

Earnings

Constellation Brand’s Earnings Report Shows Why It’s the Perfect Time to Buy

Constellation Brands Inc. (NYSE: STZ) has grown 20% in the last six months, and Wall Street projects it will grow another 46% with a high target of $288.

That’ll register as 66% growth for 2019.

But there’s plenty of reason to believe this projection is not generous enough.

Wall Street has shown, on multiple occasions, that it does not fully appreciate the growth potential of Constellation Brands.

Read more here...